WALTHAM, Mass.–(BUSINESS WIRE)–NeuroMetrix, Inc. (Nasdaq: NURO) today announced the appointment of Kenneth J. Snow, M.D. as Chief Medical Officer. The appointment was effective October 3, 2011.
“His intellect, natural curiosity, and experience will be invaluable as he leads our diabetes focused clinical programs.”
As Chief Medical Officer, Dr. Snow will be responsible for developing and managing the Company’s diabetes related clinical programs. These include studies to further validate the clinical and economic benefits of NC-stat® DPNCheck™ testing and various clinical and R&D activities in support of new diabetic neuropathy focused products in early development